4640 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. Abou-Alfa
    Abou-Alfa
  4. Kelsen
    Kelsen
  5. Ilson
    Ilson
  6. Kemeny
    Kemeny
  7. Janjigian
    Janjigian
  8. Reidy
    Reidy
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)
  7. Epidemiology and Biostatistics (828)
  8. GSK Faculty (793)
  9. Department of Pathology and Laboratory Medicine (723)
  10. Biostatistics Service (661)
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive landscape of gene amplifications (amps) in tissue and circulating tumor DNA (ctDNA) in metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Raghav, K. P. S.; Yaeger, R.; Loree, J. M.; Dasari, A.; Morris, V. K.; Kee, B. K.; Raymond, V. M.; Nagy, R. J.; Lanman, R. B.; Strickler, J. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Phase II study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinomas: Results of Part A (pembrolizumab alone)
    Meeting Abstract

    Mulvey, C.; Raj, N. P.; Chan, J. A.; Aggarwal, R. R.; Cinar, P.; Hope, T. A.; Kolli, K.; Zhang, L.; Calabrese, S.; Grabowsky, J. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Safety and clinical activity of durvalumab monotherapy in patients with microsatellite instability high (MSI-H) tumors
    Meeting Abstract

    Segal, N. H.; Wainberg, Z. A.; Overman, M. J.; Ascierto, P. A.; Arkenau, H. T.; Butler, M. O.; Eder, J. P.; Keilholz, U.; Kim, D. W.; Cunningham, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinicopathological features, efficacy of anti-EGFR therapy, and survival outcomes in patients with BRAF non-V600 mutated metastatic colorectal cancer
    Meeting Abstract

    Kotani, D.; Mondaca, S.; Parikh, A.; Bando, H.; Van Seventer, E.; Taniguchi, H.; Yoshino, T.; Corcoran, R. B.; Yaeger, R.; Ebi, H.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Updated results of the BEACON CRC safety lead-in: Encorafenib (ENCO) + binimetinib (BIM) + cetuximab (CETUX) for BRAFV600E-mutant metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Kopetz, S.; Grothey, A.; Yaeger, R.; Cuyle, P. J. A. R.; Huijberts, S.; Schellens, J. H. M.; Elez, E.; Fakih, M.; Viladot, C. M.; Peeters, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Pilot study of plasma KRAS as a prognostic biomarker in localized pancreas ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Krantz, B. A.; Gedvilaite, E.; Chou, J. F.; Capanu, M.; You, D.; Yu, K. H.; Varghese, A. M.; Iacobuzio-Donahue, C. A.; Kelsen, D. P.; Tsui, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • KRAS and TP53 status as a predictor of survival in patients with resected pancreatic ductal adenocarcinoma
    Meeting Abstract

    McIntyre, C. A.; Lawrence, S. A.; Wong, W.; Chou, J. F.; Capanu, M.; Berger, M. F.; Allen, P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Integrated population pharmacokinetic (PopPK) modeling of cabozantinib (C) in patients (pts) with various cancer types including hepatocellular carcinoma (HCC)
    Meeting Abstract

    Nguyen, L. T.; Chapel, S.; Meyer, T.; Cheng, A. L.; El-Khoueiry, A. B.; Kelley, R. K.; Abou-Alfa, G. K.; Lacy, S.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Alpha fetoprotein (AFP) response and efficacy outcomes in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Kelley, R. K.; Rimassa, L.; Ryoo, B. Y.; Park, J. W.; Blanc, J. F.; Chan, S. L.; Dadduzio, V.; Yau, T. C.; Sen, S.; Markby, D. W.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II study of ADI-PEG 20 and FOLFOX6 in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Qin, S.; Yang, T. S.; Yen, C. J.; Chao, Y.; Wang, T. E.; Do, R. K. G.; El Dika, I. H.; Uhlitskykh, K.; Millang, B. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save